Tounjian Advisory Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.2K Buy
+305
New +$35.7K 0.02% 244
2025
Q4
Sell
-12,262
Closed -$1.03M 159
2025
Q3
$1.03M Sell
12,262
-10,436
-46% -$860K 0.34% 97
2025
Q2
$2.04M Sell
22,698
-488
-2% -$38.8K 0.39% 73
2025
Q1
$2.08M Buy
+23,186
New +$2.16M 0.39% 74

Other funds holding MRK

Tounjian Advisory Partners's MRK Position: Q2 2026 in Review

Tounjian Advisory Partners opened a new position in Merck (MRK) in Q2 2026: 305 shares worth $39.2K. The stake represents 0.02% of the portfolio and ranks #244 among its holdings. This is a return to the name: Tounjian Advisory Partners previously reported a position in MRK as recently as Q3 2025.

Tounjian Advisory Partners first reported a position in MRK in Q1 2025 and has held it in 4 quarters since. The position peaked at $2.08M in Q1 2025. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Tounjian Advisory Partners held 305 shares of Merck worth $39.2K as of Q2 2026.
  • Merck was a new Tounjian Advisory Partners position in Q2 2026.
  • Merck made up 0.02% of Tounjian Advisory Partners's portfolio in Q2 2026, its #244 holding.
  • Tounjian Advisory Partners first reported a position in Merck in Q1 2025 and has held it in 4 quarters since.
  • Tounjian Advisory Partners's Merck position peaked at $2.08M in Q1 2025.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Tounjian Advisory Partners's 13F filing for Q2 2026, filed 7 Aug 2026.